Intl. Diagnostic Technology
Country not established
- Devices
- 29
What Intl. Diagnostic Technology makes
Intl. Diagnostic Technology manufactures in vitro diagnostic test kits and reagents for quantifying and detecting specific biomarkers, including theophylline, gentamicin, complement proteins (C3 and C4), rubella antibodies, IgG, IgM, total IgE, and antinuclear antibodies. The company also produces dilutors and immunoassay systems, such as the IDT ANA STIQ assay for autoimmune marker detection.
The portfolio includes Class I and Class II in vitro diagnostic devices, regulated under the FDA’s 510(k) pathway. Products are listed in the U.S. regulatory database, adhering to FDA requirements for diagnostic testing accuracy and safety. The manufacturer operates from the United States.
Catalogue
Search and filter all 29 devicesFrequently asked questions
How many devices does Intl. Diagnostic Technology have in the registry?
The registry currently lists 29 devices for Intl. Diagnostic Technology. Devices recorded under merged duplicate company entries are counted once.
Which registries list Intl. Diagnostic Technology's devices?
Among its 29 most recently registered devices, Intl. Diagnostic Technology has devices listed in FDA 510(k) (29 devices).
What risk classes do Intl. Diagnostic Technology's devices fall under?
Among its 29 most recently registered devices, the classes recorded for Intl. Diagnostic Technology's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Intl. Diagnostic Technology in the registry?
The most recently registered devices listed for Intl. Diagnostic Technology include FIAX TEST KIT FOR THEOPHYLLINE QUANT., FIAX COMPLEMENT C3 TEST KIT, RUBELLA ANTIBODY FLUOROIMMUNOASSAY and FIAX 420 DILUTOR.